MediStem Laboratories, Inc.

Category: Drugs & Pharmaceuticals

Medistem, Inc. is a biotechnology company founded to develop and commercialize technologies related to adult stem cell extraction and manipulation for use in treating inflammatory and degenerative diseases. The company's lead product, the endometrial regenerative cell (ERC), is a "universal donor" stem cell derived from menstrual blood. ERC's possesses the ability to differentiate into nine tissue types, produce large quantities of growth factors, and can be easily administered without need for invasive procedures. Due to Medistem's relationships and collaborative efforts with respected institutions, Medistem believes it is well positioned to be a leading developer of adult stem cell products.Medistem (MEDS.OB) is a US public company founded in October 2005. MediStem is HQ'ed in San Diego with a branch in Chandler, AZ.
It's mission is to discover, develop and commercialize technologies related to adult stem cell extraction and manipulation for use in treating inflammatory and degenerative diseases. The company has a portfolio of products in various stages of development covered by 15 families of patent applications.